Lexology July 8, 2024
Akin Gump Strauss Hauer & Feld LLP

Key Points

  • Loper Bright’s overruling of Chevron will affect regulations that purport to “fill a statutory gap” or interpret ambiguous statutory terms/provisions but that lack express statutory authority.
  • The decision will raise the bar for agencies like CMS and FDA when they are implementing laws where Congress left gaps or used undefined terms. Having a “permissible reading” is no longer enough; agencies must put forward the “best reading.”
  • For the small subset of cases that make it to the Supreme Court, or implicate “major questions,” Loper Bright is not a sea change. The Supreme Court has not relied on Chevron since 2016, and the Court’s “major questions” doctrine had already eliminated agency deference.
  • Many lower courts have continued to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Regulations
Federal ACA Marketplace Enrollment Lagging
CMS Launches New Program for Mental Health, OUD Treatment
Digital Twins Aren’t Just for Big Businesses
ACA enrollment lags: 3 things to know
Georgia Medicaid shakeup could force 3 in 4 beneficiaries to change plans: Centene CEO

Share This Article